March 31, 2022 | Cogstate, Decentralized trials, Impetus Digital, Natalie Yeadon, Pam Ventola, brain health, central rating, central scoring, clinical insights, clinical trials, cognitive testing, digital assessments, rare disease
Dr. Pam Ventola, Senior Science Director at Cogstate, shares how the company is working to optimize brain health assessments in rare disease and pediatric clinical trials, and how this can help advance the development of new medicines and enable earlier clinical insights. She also discusses cognitive testing as part of decentralized trials, the role of central rating and central scoring, the development of indication-specific COAs for rare disease trials, and much more.
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Robert Galarza, CEO of TruTrace Technologies, Inc., dives into the use of blockchain technology for verifying medical cannabis products and protecting intellectual property. He also shares his leadership tips and…
Hicham Naim, Global Head, Integrated & Personalized Patient Care Program, Digital Advisory Board at Takeda & Founder of Curated Health, explores digital medicine & biomarkers, outcomes-based business models, Software as…
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to…
The Honourable Tony Clement, Co-chair at Reshoring Canada and former Minister of Health, discusses digital transformation, the importance of onshore manufacturing and supply chain operations in Canada, current pharmaceutical regulatory…
Virtual engagement experts helping life science companies have ongoing conversations with their customers through our best-in-class online collaboration tools. Best-In-Class Collaboration Technology Impetus Digital provides two turn-key software solutions through…
Sara Aghvami, Director of Best Buy Health at Best Buy Canada, explores the concept of “helpful homes” and the role of digital health in enabling “aging in place.” She also…
Jennifer Helfer, Senior Director, Patient Advocacy & Engagement at Encoded Therapeutics Inc., discusses genomics-driven precision medicine, gene therapy misconceptions and fears, involving patients and caregivers in designing gene therapy trials,…
Rishi Nayyar, Co-founder & CEO of PocketHealth, explores how releasing medical imaging records straight to patients can result in data moving more ethically, easily, and securely. He also shares his…
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions.
Dr. Tarry Ahuja, Manager of Program Development in Pharmaceutical Reviews and Senior RWE Advisor at CADTH, explores the impact of COVID-19 on the biopsychosocial model of health, key opportunities and…
